Our work is guided by an external advisory panel, which meets annually to provide scientific feedback.
Advisors
Coming soon!
Past Advisors
COL Julie Ake, MD, MSc
Dr Julie Ake, a Colonel in the US Army and infectious diseases specialist, is the Director of the US Military HIV Research Program (MHRP). She is the Protocol Chair for RV 329: African Cohort Study; RV 262, an international Phase I DNA/MVA HIV vaccine trial; and for RV 398, an ongoing Phase 1 trial of the VRC01 in acute HIV infection in East Africa and Thailand, evaluating its impact on viremia and the reservoir. As the Global HIV Vaccine Product Manager for the U.S. Army, Dr. Ake advances the development of HIV vaccine candidates in preclinical and early clinical studies.
Dr Julie Ake, a Colonel in the US Army and infectious diseases specialist, is the Director of the US Military HIV Research Program (MHRP). She is the Protocol Chair for RV 329: African Cohort Study; RV 262, an international Phase I DNA/MVA HIV vaccine trial; and for RV 398, an ongoing Phase 1 trial of the VRC01 in acute HIV infection in East Africa and Thailand, evaluating its impact on viremia and the reservoir. As the Global HIV Vaccine Product Manager for the U.S. Army, Dr. Ake advances the development of HIV vaccine candidates in preclinical and early clinical studies.
Bruce Brew, MD
Prof Bruce Brew is Head of Neurosciences Program and Peter Duncan Neurosciences Unit at St Vincent's Centre for Applied Medical Research and Dept of Neurology for St Vincent's Hospital in Sydney, Australia. He has had a long standing interest in HIV neuropathogenesis, particularly in relation to cognitive impairment at both clinical and basic science levels. Prof Brew serves on editorial boards of several journals, including the Journal of Neurovirology, AIDS, Lancet HIV and other professional societies. He currently serves as President of the International Society for Neurovirology (ISNV).
Prof Bruce Brew is Head of Neurosciences Program and Peter Duncan Neurosciences Unit at St Vincent's Centre for Applied Medical Research and Dept of Neurology for St Vincent's Hospital in Sydney, Australia. He has had a long standing interest in HIV neuropathogenesis, particularly in relation to cognitive impairment at both clinical and basic science levels. Prof Brew serves on editorial boards of several journals, including the Journal of Neurovirology, AIDS, Lancet HIV and other professional societies. He currently serves as President of the International Society for Neurovirology (ISNV).
Sharon Lewin, FRACP, PhD
Sharon Lewin is the inaugural Director of the Doherty Institute at the University of Melbourne (UNIMELB); She is also a Professor of Medicine at UNIMELB and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. Her lab focuses on strategies to find a cure for HIV and understanding the interaction between HIV and hepatitis B virus. She was co-chair of the 20th International AIDS Conference, an elected member of the Governing Council of the International AIDS Society’s and chair of the Ministerial Advisory Committee for Blood Borne Viruses and Sexually Transmitted Infections. Prof Lewin has authored over 260 publications and has given over 100 international invited talks on HIV cure. In 2019, she was appointed an Officer of the Order of Australia (AO) for distinguished service to medical research, education, and clinical care in the field of infectious diseases, particularly HIV and AIDS.
Sharon Lewin is the inaugural Director of the Doherty Institute at the University of Melbourne (UNIMELB); She is also a Professor of Medicine at UNIMELB and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. Her lab focuses on strategies to find a cure for HIV and understanding the interaction between HIV and hepatitis B virus. She was co-chair of the 20th International AIDS Conference, an elected member of the Governing Council of the International AIDS Society’s and chair of the Ministerial Advisory Committee for Blood Borne Viruses and Sexually Transmitted Infections. Prof Lewin has authored over 260 publications and has given over 100 international invited talks on HIV cure. In 2019, she was appointed an Officer of the Order of Australia (AO) for distinguished service to medical research, education, and clinical care in the field of infectious diseases, particularly HIV and AIDS.
Irini Sereti, MD, MHS
Dr Sereti is Chief, HIV Pathogenesis Section for the National Institute of Allergy and Infectious Disease (NIAID). She received her MD from University of Athens, Greece, in 1991. She joined Greg Spear's lab at Rush Presbyterian Hospital in Chicago for a year and then completed her internship, residency, and chief residency in medicine at Northwestern University. In 1997, Dr Sereti joined the National Institutes of Health as a clinical associate in the Laboratory of Immunoregulation and became a staff clinician in 2003. She received tenure in 2015. Her primary research focus is the study of inflammatory complications in HIV, including immune reconstitution inflammatory syndrome (IRIS).
Dr Sereti is Chief, HIV Pathogenesis Section for the National Institute of Allergy and Infectious Disease (NIAID). She received her MD from University of Athens, Greece, in 1991. She joined Greg Spear's lab at Rush Presbyterian Hospital in Chicago for a year and then completed her internship, residency, and chief residency in medicine at Northwestern University. In 1997, Dr Sereti joined the National Institutes of Health as a clinical associate in the Laboratory of Immunoregulation and became a staff clinician in 2003. She received tenure in 2015. Her primary research focus is the study of inflammatory complications in HIV, including immune reconstitution inflammatory syndrome (IRIS).
Netanya Utay, MD
Dr. Netanya Utay is an associate professor at UT Health Science Center at Houston. She completed her BS in Biophysics and Biochemistry at Yale University in 1998, attended medical school at Baylor College of Medicine and internal medicine residency at the University of Washington. During infectious diseases fellowship at the NIH, she worked in the laboratory of Dr. Daniel Douek, investigating the causes and consequences of inflammation in HIV infection. She currently maintains a busy outpatient HIV clinic, chairs several local clinical studies, and oversees a laboratory focused on the causes and consequences of inflammation in acute and chronic infections with HIV.
Dr. Netanya Utay is an associate professor at UT Health Science Center at Houston. She completed her BS in Biophysics and Biochemistry at Yale University in 1998, attended medical school at Baylor College of Medicine and internal medicine residency at the University of Washington. During infectious diseases fellowship at the NIH, she worked in the laboratory of Dr. Daniel Douek, investigating the causes and consequences of inflammation in HIV infection. She currently maintains a busy outpatient HIV clinic, chairs several local clinical studies, and oversees a laboratory focused on the causes and consequences of inflammation in acute and chronic infections with HIV.